Dear <<First Name>>,
Summer is finally here. About time to deliver some hot news, some of them so hot off the oven, they are still steaming.
In this past quarter, we have completed
two investments and participated in
three major follow-on financing rounds:
We are happy to welcome
vasopharm to our family, a Würzburg-based pharmaceutical company dedicated to the discovery and development of novel therapeutics for the treatment of cerebrovascular diseases.
The second investment is actually still so hot that we cannot communicate it yet. You will learn about it in our next newsletter at the latest.
We are proud to win Notion Capital as a new investor in
HeyJobs' recent EUR 10 million Series A round. We participated in
Wunderflat's EUR 7+ million strong Series A round to further shake up the market for furnished long-term stays. And we also doubled down on
CryoTherapeutics to further help them on their path to develop and commercialize cryotherapy systems for the treatment of coronary plaque to treat and prevent heart attacks.
Further highlights of this packed quarter include the expansion of
Blueprint Genetics' operations in the US and the opening of an office in LA for
Imverse, a major product launch for
Allthings, the introduction of crypto currencies as a means of payment at
iFunded, and free ESOP and PSOP templates for Swiss founders by
Ledgy (whose three founders Yoko, Ben and Timo have been included in this year's
Forbes 30 Under 30 DACH list, by the way).
Last but not least, we have launched an interview series with the founders or CEOs of our portfolio companies called
Make It Ten that allows you to get to know our portfolio much better. Why that name, you ask? Well, find it out on our Medium blog.
Enjoy your summer!
Sincerely,
Your Creathor Team
